Search

everythinglearnresearchcommunity

for

Search:↓

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

A woman's significant hair loss was linked to rapid weight loss and hormone injections.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Men with androgenetic alopecia have lower levels of certain proteins and more cell damage.

The exact cause of male pattern baldness is unclear, but it may involve factors beyond androgens, offering new treatment possibilities.

Hair loss is caused by mechanical, thermal, and metabolic factors, not just hormones.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

An ovarian tumor can cause high male hormones in postmenopausal women.

Metformin is less effective in men with early-onset hair loss.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Thinner hair follicle structures are linked to non-scar alopecia.